Simplify Logo

Full-Time

Pioneering Medicines Principal Scientist/Associate Director

Cardiovascular

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Venture Capital

Expert

Cambridge, MA, USA

Category
Lab & Research
Life Sciences
Required Skills
Communications
Requirements
  • PhD in relevant scientific discipline with 12+ years of relevant experience
  • In-depth knowledge of (patho-)physiology of cardiovascular, renal and pulmonary mechanisms, including direct experience complex in vitro cell-based platforms recapitulating human disease phenotype and in vivo models of disease progression
  • Extensive “hands-on” experience and track-record in the use of a wide range of cellular, biochemical and functional assays and technologies to unravel complex cellular signaling pathways.
  • Track record of leading discovery projects to elucidate mechanistic target biology and validation in the disease areas.
  • A proven scientific impact on innovation through a solid publication track record and strong external scientific network with academic experts.
  • Excellent oral and written English communication skills, with an ability to effectively interact with people in a dynamic matrix environment, both internally and externally
Responsibilities
  • Contribute to the drug discovery process with a goal to nominate targets with proof of concepts studies
  • Act as a leader of a team tasked with screening, characterization, and mechanism of action studies to elucidate signaling pathways for target identification, and validation utilizing complex cellular models, various modalities, including small molecules, biologics, gene editing, and omics approaches through AI and ML
  • Conduct research in areas of cardiovascular, pulmonary and/or renal disease space by acting as a subject matter expertise.
  • Lead early drug projects in the cardiovascular, pulmonary and/or renal disease space, propose and champion new targets and novel approaches for disease treatment.
  • Design and execute in vitro and in vivo research plans to evaluate targets modulating pathways in cardiovascular, pulmonary and/or renal diseases
  • Develop assays and implement new technologies to enable the delivery of high quality data-driven package and enable project decisions go/no-go portfolio transitions.
  • Record and interpret experimental data, and present results to project team members.
  • Collaborate with other scientists in a global matrixed dynamic environment fostering innovation and advance project activities. Develop and maintain external relationships/contacts.
  • Deliver impact to projects by identifying technical trends, both internal and external to your subject area.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.